Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19,756 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical significance of pAKT and CD44v6 overexpression with breast cancer.
Yu P, Zhou L, Ke W, Li K. Yu P, et al. Among authors: zhou l. J Cancer Res Clin Oncol. 2010 Aug;136(8):1283-92. doi: 10.1007/s00432-010-0779-x. Epub 2010 Feb 16. J Cancer Res Clin Oncol. 2010. PMID: 20157733
Molecular markers of therapeutic resistance in breast cancer.
Zhou L, Luo Y, Li K, Tian L, Wang M, Li C, Huang Q. Zhou L, et al. Hum Pathol. 2013 Jul;44(7):1421-8. doi: 10.1016/j.humpath.2012.10.027. Epub 2013 Feb 21. Hum Pathol. 2013. PMID: 23434145
Novel prognostic markers for patients with triple-negative breast cancer.
Zhou L, Li K, Luo Y, Tian L, Wang M, Li C, Huang Q. Zhou L, et al. Hum Pathol. 2013 Oct;44(10):2180-7. doi: 10.1016/j.humpath.2013.03.021. Epub 2013 Jul 8. Hum Pathol. 2013. PMID: 23845466
MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research.
Ke W, Yu P, Wang J, Wang R, Guo C, Zhou L, Li C, Li K. Ke W, et al. Among authors: zhou l. Med Oncol. 2011 Dec;28 Suppl 1:S135-41. doi: 10.1007/s12032-010-9747-1. Epub 2010 Nov 30. Med Oncol. 2011. PMID: 21116879
Expression of pAkt is associated with a poor prognosis in Chinese women with invasive ductal breast cancer.
Zhou L, Wang M, Guo C, Zhu Y, Yu H, Zhang L, Yu P. Zhou L, et al. Oncol Lett. 2018 Apr;15(4):4859-4866. doi: 10.3892/ol.2018.7965. Epub 2018 Feb 6. Oncol Lett. 2018. PMID: 29552125 Free PMC article.
Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.
Zhang Z, Wang M, Zhou L, Feng X, Cheng J, Yu Y, Gong Y, Zhu Y, Li C, Tian L, Huang Q. Zhang Z, et al. Among authors: zhou l. J Exp Clin Cancer Res. 2015 May 20;34(1):51. doi: 10.1186/s13046-015-0166-1. J Exp Clin Cancer Res. 2015. PMID: 25986235 Free PMC article.
ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC.
Cheng Q, Zhou L, Zhou J, Wan H, Li Q, Feng Y. Cheng Q, et al. Among authors: zhou j, zhou l. Oncol Rep. 2016 Sep;36(3):1403-10. doi: 10.3892/or.2016.4967. Epub 2016 Jul 22. Oncol Rep. 2016. PMID: 27460845
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, Jimeno A, Raben D, Bedford JS, Li CY. Huang Q, et al. Among authors: zhou l. Nat Med. 2011 Jul 3;17(7):860-6. doi: 10.1038/nm.2385. Nat Med. 2011. PMID: 21725296 Free PMC article.
MicroRNA-155 regulates the proliferation, cell cycle, apoptosis and migration of colon cancer cells and targets CBL.
Yu H, Xu W, Gong F, Chi B, Chen J, Zhou L. Yu H, et al. Among authors: zhou l. Exp Ther Med. 2017 Nov;14(5):4053-4060. doi: 10.3892/etm.2017.5085. Epub 2017 Aug 31. Exp Ther Med. 2017. PMID: 29104623 Free PMC article.
Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC.
Miao L, Chen W, Zhou L, Wan H, Gao B, Feng Y. Miao L, et al. Among authors: zhou l. Sci Rep. 2016 Feb 17;6:21359. doi: 10.1038/srep21359. Sci Rep. 2016. PMID: 26883083 Free PMC article.
19,756 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page